A New Brand of Creative Leadership

Blue Spoon is the global leader in positioning strategy at a system level. It is led by its Founder and Executive Director, John G. Singer.

A health industry contextualist, John brings a complete vision for market innovation from 25+ years of deep, diverse and unique experience as a practitioner, business manager and senior leader in big technology, digital health, marketing, strategic communications, innovation consulting and industry thought leadership across all dimensions of the global health sector, including pharmaceutical, medical device, payer and provider contexts.

Over the course of his career, John has helped position, launch and market dozens of products, medical devices, pharmaceuticals and new operating models from clients that have included Pfizer, Merck, Johnson & Johnson, Janssen, UCB, Takeda, Gilead Sciences, Roche, Bayer, the Veteran’s Health Administration, Blue Cross/Blue Shield and MU Health, among many others. He has supported hedge funds and global investment firms, helping them understand the competitive landscape, pricing dynamics and regulatory overview in the market for health information technologies, and advised the biggest brands in management consulting on strategic innovation.

John has published new business thinking and ideas in some of the most influential media in the world, including Fortune, MIT Sloan Management Review, the Wall Street Journal, the Journal of Business Strategy, and the Oxford Handbook of Innovation Management. His insights and thought leadership on the future of strategy and competition was used by the U.S. Army War College to position innovation initiatives and capability development for its Third Offset Strategy, a doctrine by the Department of Defense to achieve broad-based innovation across the spectrum of concepts, research and development, leadership education and business practices. 

John is also a guest speaker on market innovation and ecosystem-centered business strategy at leading professional organizations and business schools, including Athens University of Economics and Business, California Association of Physician Groups, Cambridge University, ESCP Europe, HEC Lausanne, ISPOR, McGill University, New York Medical College, New York University Stern School of Business, RAND Corporation, Rutgers University, Society for Clinical Data Management, Thomas Jefferson University Population Health Colloquium, and the VHA Innovation Experience.

In his most recent role as Chief Strategy Officer, Healthcare for Cognizant Technology Solutions (NYSE: CTSH), John led industry strategy, mergers and acquisitions, market development, strategic sales and executive engagement for new value propositions and emerging technologies across Cognizant’s $4 billion healthcare portfolio. Before joining Cognizant, John was the Global Head of Health Market Strategy, Innovation and Technology for Wipro (NYSE: WIT), a leading technology services company. Prior to Wipro, he led the U.S. Healthcare Practice at RAPP, a CXM/marketing service within Omnicom Group that helped clients deal with the emergence of a digital sixth sense. While at RAPP, John led digital strategy and consumer experience design for the launch of Solvadi, Gilead Sciences’ cure for Hepatitis C, directed the development of patient engagement as a strategic pillar for JNJ Diabetes Solutions, and managed the first e-commerce platform in the pharmaceutical industry.